Does IPTACOPAN Cause Breakthrough haemolysis? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Breakthrough haemolysis have been filed in association with IPTACOPAN (FABHALTA). This represents 4.7% of all adverse event reports for IPTACOPAN.
22
Reports of Breakthrough haemolysis with IPTACOPAN
4.7%
of all IPTACOPAN reports
0
Deaths
7
Hospitalizations
How Dangerous Is Breakthrough haemolysis From IPTACOPAN?
Of the 22 reports, 7 (31.8%) required hospitalization.
Is Breakthrough haemolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPTACOPAN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does IPTACOPAN Cause?
Headache (63)
Fatigue (45)
Diarrhoea (32)
Nausea (32)
Haemoglobin decreased (31)
Pyrexia (25)
Product dose omission issue (23)
Rash (22)
Drug ineffective (21)
Off label use (20)
What Other Drugs Cause Breakthrough haemolysis?
Which IPTACOPAN Alternatives Have Lower Breakthrough haemolysis Risk?
IPTACOPAN vs IRBESARTAN
IPTACOPAN vs IRINOTECAN
IPTACOPAN vs IRON
IPTACOPAN vs IRON DEXTRAN
IPTACOPAN vs IRON ISOMALTOSIDE 1000